Materialise, a leader in 3D printing software and services, has acquired FEops, a Belgian company specializing in AI-driven simulation technology for structural heart interventions. The acquisition will expand Materialise’s cardiovascular solutions by integrating FEops’ predictive simulation capabilities to enhance personalized treatment for patients with heart diseases. The transaction amount was not disclosed.
FEops combines predictive simulation technology and artificial intelligence to help clinicians predict how transcatheter structural heart devices will interact with a patient’s anatomy. By integrating FEops’ technology with Materialise’s Mimics Planner for Structural Heart Interventions, clinicians can simulate how a medical device, such as a heart valve, will interact with a patient’s unique anatomy before the procedure, resulting in improved accuracy, efficiency, and patient safety.
The advancement in simulation technology is set to transform patient care for structural heart diseases by offering a more interactive and AI-based solution for preparing heart procedures. This technology will enable the expansion of transcatheter procedures to a broader range of patients and improve overall outcomes.
Heart valve diseases represent a significant medical and economic challenge worldwide, with an increasing number of people suffering from these conditions. By advancing mass personalization in healthcare through advanced visualization and 3D printing technologies, Materialise aims to improve the precision and success of complex procedures, ultimately enhancing patient outcomes and making personalized healthcare more accessible.
Source
Photo credit www.voxelmatters.com